Mymetics Quick Ratio (MYMX) starting from the third quarter 2023 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Mymetics Corporation  (MYMX)

Mymetics's Quick Ratio

MYMX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




Within Biotechnology & Pharmaceuticals industry Mymetics Corporation booked the highest Quick Ratio than Mymetics in the third quarter 2023. While total ranking remained the same in the Q3 2023 compared to the second quarter 2023 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents MYMX´s has?
What are MYMX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MYMX/financial-strength
https://api.csimarket.com/api/v1/companies/MYMX/fundamentals
https://api.csimarket.com/api/v1/companies/MYMX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
MYMX Quick Ratio (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2 		(Mar 31 2023)
Q1 		(Dec 31 2022)
Q4 		(Sep 30 2022)
Q3
Y / Y Current Liabilities Change 6.04 %
Y / Y Cash & cash equivalent Change -
Quick Ratio MRQ -
MYMX's Total Ranking #
Seq. Current Liabilities Change 0.92 %
Seq. Cash & cash equivalent Change -



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Mymetics's Current Liabilities $ 85 Millions Visit MYMX's Balance sheet
Mymetics's Cash & cash equivalent $ 0 Millions Visit MYMX's Balance sheet
Source of MYMX's Sales Visit MYMX's Sales by Geography


Cumulative Mymetics's Quick Ratio

MYMX's Quick Ratio for the trailling 12 Months

MYMX Quick Ratio

 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months 		(Mar 31 2023)
12 Months 		(Dec 31 2022)
12 Months 		(Sep 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth 34.25 %
Y / Y Cash & cash equivalent TTM Growth -53.72 %
Quick Ratio TTM 0
Total Ranking TTM # 4285
Seq. Current Liabilities TTM Growth 1.23 %
Seq. Cash & cash equivalent TTM Growth -38.75 %

Quick ratio ranking by company, industry and sector >> Back to MYMX Financial Strength Comparisons >> Go to Compare MYMX Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the unchanged in Current Liabilities in the Q3 2023 to $84.59 millions, cumulative Quick Ratio